Pharmacological adjuvants for surgical treatment of proliferative vitreoretinopathy

被引：11
|
作者：
Scheer, S [1 ]
Morel, C [1 ]
Touzeau, O [1 ]
Laroche, L [1 ]
Sahel, JA [1 ]
机构：
[1] CHNO Quinze Vingts, F-75012 Paris, France
来源：
JOURNAL FRANCAIS D OPHTALMOLOGIE | 2004年 / 27卷 / 09期
关键词：
proliferative vitreoretinopathy; adjuvants; retinal detachment; daunomycin; 5-fluorouracile; steroids; heparin; colchicine; 13-cis retinoic acid; silicone;
D O I：
10.1016/S0181-5512(04)96264-X
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
Proliferative vitreoretinopathy (PVR) is the major cause of retinal detachment surgery failure. Many adjuvants were studied in vitro and on animals, some were studied on humans. Daunomycin seems to reduce PVR recidivism. 5-FU and steroids are nontoxic but their efficacy is not clear. Heparin reduced postoperative inflammation and seems to reduce PVR recidivism when associated with 5-FU. Associating heparin and steroids seems to reduce PVR in some groups of patients (aphakic, anterior PVR). Colchicine and retinoic acid per os are ineffective, silicone oil is effective as an internal tamponade but not as an adjuvant of PVR. Currently, no molecule has proven efficacy as an adjunctive treatment of PVR.
引用
收藏
页码：1051 / 1059
页数：9
相关论文
共 50 条
  • [21] A Porcine Model of Proliferative Vitreoretinopathy
    Bansal, A. S.
    Grossniklaus, H. E.
    Olsen, T. W.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [22] Molecular Targets for Proliferative Vitreoretinopathy
    Wu, Frances
    Eliott, Dean
    SEMINARS IN OPHTHALMOLOGY, 2021, 36 (04) : 218 - 223
  • [23] Evaluation of retinectomy in the treatment of severe proliferative vitreoretinopathy
    Mendes T.S.
    Gomes A.M.V.
    Rocha B.S.
    Passos Junior H.V.
    Abujamra S.
    International Journal of Retina and Vitreous, 1 (1)
  • [24] Evaluation of a steroid delivery system to mitigate the severity of proliferative vitreoretinopathy in a minipig model
    Wong, Chee Wai
    Cheung, Ning
    Howden, James S.
    Busoy, Joanna Marie Fianza
    Sim, Shaun
    Lim, Joshua
    Ho, Candice
    Veluchamy, Amutha Barathi
    Storm, Gert
    Wong, Tina T.
    FRONTIERS IN OPHTHALMOLOGY, 2023, 3
  • [25] Intravitreal triamcinolone for treatment of complicated proliferative diabetic retinopathy and proliferative vitreoretinopathy
    Munir, WM
    Pulido, JS
    Sharma, MC
    Buerk, BM
    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2005, 40 (05): : 598 - 604
  • [26] Proliferative vitreoretinopathy (PVR) minimal: same, same but different. Characteristics and surgical treatment of PVR-associated macular pucker
    Hattenbach, L. -O.
    Grisanti, S.
    Priglinger, S. G.
    Chronopoulos, A.
    OPHTHALMOLOGE, 2021, 118 (01): : 24 - 29
  • [27] Proliferative vitreoretinopathy: revised concepts of pathogenesis and adjunctive treatment
    Charteris, David G.
    EYE, 2020, 34 (02) : 241 - 245
  • [28] Apoptotic cell death in proliferative vitreoretinopathy
    Esser, P
    BartzSchmidt, KU
    Walter, P
    Kaszli, F
    Heimann, K
    Weller, M
    GERMAN JOURNAL OF OPHTHALMOLOGY, 1996, 5 (02) : 73 - 78
  • [29] BIODEGRADABLE MICROSPHERES CONTAINING ADRIAMYCIN IN THE TREATMENT OF PROLIFERATIVE VITREORETINOPATHY
    MORITERA, T
    OGURA, Y
    YOSHIMURA, N
    HONDA, Y
    WADA, R
    HYON, SH
    IKADA, Y
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1992, 33 (11) : 3125 - 3130
  • [30] Proliferative vitreoretinopathy: current and emerging treatments
    Sadaka, Ama
    Giuliari, Gian Paolo
    CLINICAL OPHTHALMOLOGY, 2012, 6 : 1325 - 1333
12345